Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Personalized Medicine is Scopus-indexed (Q2, CiteScore 2.7), WoS SCIE. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 1741-0541Verify ISSN ↗1744-828XVerify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 219 / 669 | 67th | Q2 |
| Pharmacology | 221 / 328 | 32nd | Q3 |
| Molecular Medicine | 148 / 179 | 17th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2006–present, best quartile Q2, CiteScore 2.7.
Personalized Medicine is Q2 in Medicine (all) (rank 219 of 669), Q3 in Pharmacology (rank 221 of 328) and Q4 in Molecular Medicine (rank 148 of 179), by CiteScore 2025.
Personalized Medicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.7, which places it in quartile Q2 at the 67th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.357, quartile Q3, with an H-index of 40.
Personalized Medicine is published by Taylor and Francis Ltd. Its print ISSN is 1741-0541 and its online ISSN is 1744-828X.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Personalized Medicine has an h-index of 50 and a 2-year mean of 1.29 citations per paper (OpenAlex). Its Scopus CiteScore is 2.7, quartile Q2. On 2-year citations it ranks #216 of 646 Scopus journals in Medicine (all).
Personalized Medicine published 51 papers in 2025; its busiest recent year was 2018 with 82. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2024–2026), authors are most often from China (14.8%), Iran (13%) and United States (12.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.